The goal of this study is to identify a serum biomarker(s) that can detect increased levels of a population of CD15+ hypodense neutrophils termed low-density granulocytes (LDG) in the blood of patients with severe persistent asthma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of low density granulocytes (LDG) in the peripheral blood mononuclear cell (PBMC)
Timeframe: Visit 1 day
mRNA levels in severe asthmatics as analyzed by gene profiling analysis
Timeframe: Visit 1 day